Memo To Research University Presidents: Change The Ship's Course

Editor's Note: Nobel laureate Leon Lederman, director emeritus of the Fermi National Accelerator Laboratory who is also a professor of science at the Illinois Institute of Technology, is perturbed about what he believes is a lack of zeal in the way top-level administrators at United States research universities are confronting a general decline in the fortunes of their institutions. Federal policies in the support of research and increasing administrative pressures are putting them at risk, Le

Written byLeon Lederman
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

In June 1994, Lederman attended a symposium at the University of California, Los Angeles, on challenges facing academia, at which many university administrators were present. The remarks of these officials prompted him to deliver a response, an edited version of which is reprinted here with a new introduction by Lederman.

The U.S. university system, and, in particular, the research universities, are under considerable stress. These powerful institutions for research and education emerged after World War II as a uniquely American invention that successfully blended teaching and research, in contrast to the European models in which the two activities were separate. Graduate education in the U.S. became preeminent in the world and, even today, U.S. graduate school education is one of our most successful "exports," as almost 50 percent of the population of U.S. graduate schools in mathematics, science, and engineering are populated by foreign students.

The problems facing research universities--someone ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies